Philip is a Partner in our Corporate Team and Head of Corporate, Commercial and Employment Teams.
He is a transactional M&A lawyer with over 30 years’ extensive corporate experience, acting mainly for sellers on share and asset deals. He also specialises in management buy-outs, joint ventures and reorganisations and increasingly is relied on by clients for overall strategic and commercial advice.
He works with a mixture of regional, national and international clients and has acted on the sale on a number of high-profile life sciences and technology companies to overseas buyers.
He is frequently recommended as a key individual in Legal 500 and Chambers and Partners, the two main independent legal guides:
- Acting for the management team in a £12.75m private equity funded management buy-out of veterinary training business, Improve International Limited, from its listed parent company.
- Acting as legal advisers to the shareholders of specialist life sciences company, Absolute Antibody Ltd (UK) and its sister company Kerafast, on their sale to LSBio (USA).
- Advised the shareholders of UK-based skincare brand Argentum Apothecary on its sale to luxury Chinese beauty group USHOPAL.
- Advising the shareholders of leading protective packaging specialists, GWP Holdings Limited, on their sale to Macfarlane Group Limited (a wholly owned subsidiary of listed-company Macfarlane Group PLC) for up to £15.1million, plus around £3 million of net assets.